The anti‑c‑MET ADC binds c‑MET on target cells, is internalized, and the val‑cit linker is cleaved in acidic compartments to release MMAE, which inhibits tubulin polymerization, causing microtubule disruption, G2/M arrest, and apoptosis of c‑MET–expressing cells.